Using paired normal and tumor DNA from the same patients, we identified and validated a few novel recurrent somatic mutations in LGSOC, in addition to KRAS, BRAF, USP9X, and EIF1AX mutations that have been identified in previous studies. The gene discussed is USP9X; the disease is neoplasm.